Free Trial
NASDAQ:GEHC

GE HealthCare Technologies (GEHC) Stock Price, News & Analysis

GE HealthCare Technologies logo
$74.07 -0.31 (-0.42%)
As of 04:00 PM Eastern

About GE HealthCare Technologies Stock (NASDAQ:GEHC)

Key Stats

Today's Range
$73.57
$74.58
50-Day Range
$60.48
$74.86
52-Week Range
$57.65
$94.80
Volume
2.58 million shs
Average Volume
3.51 million shs
Market Capitalization
$33.92 billion
P/E Ratio
15.59
Dividend Yield
0.19%
Price Target
$88.27
Consensus Rating
Moderate Buy

Company Overview

GE HealthCare Technologies, Inc. (NASDAQ: GEHC) is a global leader in medical technology and life sciences, offering a wide array of products and services designed to improve patient care and streamline clinical workflows. Formed as an independent public company following its separation from General Electric in early 2023, GE HealthCare combines decades of innovation in diagnostic imaging, ultrasound, molecular imaging, and digital health solutions. The company’s mission is to drive precision health by harnessing data, analytics, and advanced technology to deliver better outcomes for patients and providers.

In its diagnostic imaging portfolio, GE HealthCare provides a comprehensive range of modalities, including computed tomography (CT), magnetic resonance imaging (MRI), X-ray, nuclear imaging, and interventional imaging systems. The company’s ultrasound division offers point-of-care and radiology ultrasound systems, as well as contrast imaging and women’s health solutions. Complementing its hardware offerings, GE HealthCare has invested heavily in digital platforms and artificial intelligence, delivering cloud-based software that supports image analysis, workflow optimization, and remote collaboration among healthcare teams.

Beyond medical imaging, GE HealthCare serves the life sciences and cell therapy markets with bioprocessing technologies, single-use systems, and automation platforms. These solutions enable pharmaceutical and biotechnology companies to accelerate drug discovery, large-scale biologics production, and emerging therapies such as cell and gene treatments. By integrating process analytics and digital twins, the company aims to enhance manufacturing efficiency, consistency, and regulatory compliance across research and production environments.

Headquartered in Chicago and operating in more than 140 countries, GE HealthCare is led by President and Chief Executive Officer Kieran Murphy, alongside a diverse executive team with deep industry expertise. The company’s global footprint encompasses research and development centers, manufacturing facilities, and service operations, ensuring localized support for customers in North America, Europe, Asia-Pacific, and emerging markets. With a commitment to sustainability and equitable access to care, GE HealthCare continues to collaborate with healthcare providers, governments, and non-profit organizations to address critical challenges in global health.

AI Generated. May Contain Errors.

GE HealthCare Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
83rd Percentile Overall Score

GEHC MarketRank™: 

GE HealthCare Technologies scored higher than 83% of companies evaluated by MarketBeat, and ranked 189th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GE HealthCare Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GE HealthCare Technologies has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about GE HealthCare Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for GE HealthCare Technologies are expected to grow by 11.11% in the coming year, from $4.68 to $5.20 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GE HealthCare Technologies is 15.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.92.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GE HealthCare Technologies is 15.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.49.

  • Price to Earnings Growth Ratio

    GE HealthCare Technologies has a PEG Ratio of 2.51. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    GE HealthCare Technologies has a P/B Ratio of 4.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about GE HealthCare Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    1.40% of the float of GE HealthCare Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    GE HealthCare Technologies has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GE HealthCare Technologies has recently increased by 3.57%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    GE HealthCare Technologies has a dividend yield of 0.19%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    GE HealthCare Technologies has only been increasing its dividend for 1 years.

  • Dividend Coverage

    The dividend payout ratio of GE HealthCare Technologies is 2.95%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, GE HealthCare Technologies will have a dividend payout ratio of 2.69% next year. This indicates that GE HealthCare Technologies will be able to sustain or increase its dividend.

  • Read more about GE HealthCare Technologies' dividend.
  • Percentage of Shares Shorted

    1.40% of the float of GE HealthCare Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    GE HealthCare Technologies has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GE HealthCare Technologies has recently increased by 3.57%, indicating that investor sentiment is decreasing.
  • News Sentiment

    GE HealthCare Technologies has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.91 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 22 news articles for GE HealthCare Technologies this week, compared to 15 articles on an average week.
  • Search Interest

    21 people have searched for GEHC on MarketBeat in the last 30 days. This is an increase of 31% compared to the previous 30 days.
  • MarketBeat Follows

    Only 7 people have added GE HealthCare Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -46% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GE HealthCare Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.27% of the stock of GE HealthCare Technologies is held by insiders.

  • Percentage Held by Institutions

    82.06% of the stock of GE HealthCare Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about GE HealthCare Technologies' insider trading history.
Receive GEHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.

GEHC Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

GEHC Stock Analysis - Frequently Asked Questions

GE HealthCare Technologies' stock was trading at $78.18 at the start of the year. Since then, GEHC stock has decreased by 5.2% and is now trading at $74.1040.
View the best growth stocks for 2025 here
.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) released its quarterly earnings data on Wednesday, April, 30th. The company reported $1.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. The firm's revenue was up 2.7% on a year-over-year basis.
Read the conference call transcript
.

GE HealthCare Technologies' board initiated a stock buyback program on Wednesday, April 30th 2025, which allows the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 3.1% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued.

Shares of GEHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GE HealthCare Technologies investors own include Chevron (CVX), Bristol Myers Squibb (BMY), Humana (HUM), Comcast (CMCSA), American Water Works (AWK), McKesson (MCK) and Charles Schwab (SCHW).

Company Calendar

Record date for 5/15 Dividend
4/25/2025
Ex-Dividend for 5/15 Dividend
4/25/2025
Last Earnings
4/30/2025
Dividend Payable
5/15/2025
Today
6/30/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:GEHC
Previous Symbol
NASDAQ:GEHC
Fax
N/A
Employees
50,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$88.27
High Stock Price Target
$103.00
Low Stock Price Target
$73.00
Potential Upside/Downside
+18.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
12 Analysts

Profitability

Trailing P/E Ratio
15.66
Forward P/E Ratio
15.89
P/E Growth
2.51
Net Income
$1.99 billion
Pretax Margin
13.95%

Debt

Sales & Book Value

Annual Sales
$19.67 billion
Cash Flow
$5.78 per share
Price / Cash Flow
12.87
Book Value
$18.53 per share
Price / Book
4.01

Miscellaneous

Free Float
456,649,000
Market Cap
$34.06 billion
Optionable
Optionable
Beta
1.14
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:GEHC) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners